Fonar Corp (FONR)
16.86
+0.67
(+4.14%)
USD |
NASDAQ |
Apr 25, 16:00
16.80
-0.06
(-0.36%)
Pre-Market: 20:00
Fonar Debt to Equity Ratio: 0.0008 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
December 31, 2023 | 0.0008 |
September 30, 2023 | 0.0009 |
June 30, 2023 | 0.001 |
March 31, 2023 | 0.0011 |
December 31, 2022 | 0.0012 |
September 30, 2022 | 0.0012 |
June 30, 2022 | 0.0013 |
March 31, 2022 | 0.0014 |
December 31, 2021 | 0.0015 |
September 30, 2021 | 0.0016 |
June 30, 2021 | 0.0067 |
March 31, 2021 | 0.007 |
December 31, 2020 | 0.0075 |
September 30, 2020 | 0.008 |
June 30, 2020 | 0.0077 |
March 31, 2020 | 0.0022 |
December 31, 2019 | 0.0023 |
September 30, 2019 | 0.0025 |
June 30, 2019 | 0.0027 |
March 31, 2019 | 0.0029 |
December 31, 2018 | 0.0031 |
September 30, 2018 | 0.0032 |
June 30, 2018 | 0.0035 |
March 31, 2018 | 0.0041 |
December 31, 2017 | 0.0049 |
Date | Value |
---|---|
September 30, 2017 | 0.0058 |
June 30, 2017 | 0.0067 |
March 31, 2017 | 0.0155 |
December 31, 2016 | 0.0334 |
September 30, 2016 | 0.0532 |
June 30, 2016 | 0.086 |
March 31, 2016 | 0.1323 |
December 31, 2015 | 0.1551 |
September 30, 2015 | 0.1834 |
June 30, 2015 | 0.2133 |
March 31, 2015 | 0.2819 |
December 31, 2014 | 0.3208 |
September 30, 2014 | 0.3735 |
June 30, 2014 | 0.4493 |
March 31, 2014 | 0.5899 |
December 31, 2013 | 0.7154 |
September 30, 2013 | 0.8873 |
June 30, 2013 | 1.118 |
March 31, 2013 | 1.716 |
December 31, 2012 | 0.2665 |
September 30, 2012 | 0.3671 |
June 30, 2012 | 0.5257 |
March 31, 2012 | 0.793 |
December 31, 2011 | 1.645 |
September 30, 2011 | 19.80 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.0008
Minimum
Dec 2023
0.008
Maximum
Sep 2020
0.0031
Average
0.0016
Median
Sep 2021
Debt to Equity Ratio Benchmarks
XWELL Inc | 0.00 |
ProPhase Labs Inc | 0.2077 |
Applied DNA Sciences Inc | 0.00 |
Veracyte Inc | 0.00 |
OncoCyte Corp | 0.00 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 202.26M |
Total Liabilities (Quarterly) | 45.96M |
Shareholders Equity (Quarterly) | 163.89M |
Current Ratio | 9.348 |
Net Debt Paydown Yield | 0.01% |